Evidence map›Paper›PMID 18812464›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2008

Prepubertal OVX increases IGF-I expression and bone accretion in C57BL/6J mice.

Kristen E Govoni, Jon E Wergedal, Robert B Chadwick, Apurva K Srivastava, Subburaman Mohan

Abstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Does the GH/IGF-1 axis contribute to skeletal sexual dimorphism? Evidence from mouse studies.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2016
    Review
  8. Sex steroid actions in male bone.Endocrine reviews · 2014
    Review
  9. Article
  10. Reduced bone turnover in mice lacking the P2Y13 receptor of ADP.Molecular endocrinology (Baltimore, Md.) · 2012
    Article
  11. Article
  12. Hypothalamic suppression during adolescence varies by bone envelope.Medicine and science in sports and exercise · 2011
    Article
  13. Review
  14. Lengthening of mouse hindlimbs with joint loading.Journal of bone and mineral metabolism · 2010
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kristen E GovoniJerry L. Pettis Memorial Veterans Affairs Medical Center, Loma Linda, California 92357, USA.
Jon E Wergedal
Robert B Chadwick
Apurva K Srivastava
Subburaman Mohan
Jerry L. Pettis Memorial VA Medical Center · US

Funding

Transgenic Approaches to Evaluate IGF-I Role in Peak BMDR01AR048139 · NIAMS · LOMA LINDA VETERANS ASSN RESEARCH &EDUC · PI MOHAN, SUBBURAMAN · 2003 to 2025
$4.7M
Transgenic Approaches to Evalute IGF-1 Role in Peak BMDR56AR048139 · NIAMS · LOMA LINDA VETERANS ASSN RESEARCH & EDUC · PI MOHAN, SUBBURAMAN · 2008 to 2008
$258k
NIAMS NIH HHS AR-048139NIAMS NIH HHS R01 AR048139NIAMS NIH HHS R56 AR048139
6 · The paper itself

Abstract

It is generally well accepted that the pubertal surge in estrogen is responsible for the rapid bone accretion that occurs during puberty and that this effect is mediated by an estrogen-induced increase in growth hormone (GH)/insulin-like growth factor (IGF) action. To test the cause and effect relationship between estrogen and GH/IGF, we evaluated the consequence of ovariectomy (OVX) in prepubertal mice (C57BL/6J mice at 3 wk of age) on skeletal changes and the GH/IGF axis during puberty. Contrary to our expectations, OVX increased body weight (12-18%), bone mineral content (11%), bone length (4%), bone size (3%), and serum, liver, and bone IGF-I (30-50%) and decreased total body fat (18%) at 3 wk postsurgery. To determine whether estrogen is the key ovarian factor responsible for these changes, we performed a second experiment in which OVX mice were treated with placebo or estrogen implants. In addition to observing similar results compared with our first experiment, estrogen treatment partially rescued the increased body weight and bone size and completely rescued body fat and IGF-I levels. The increased bone accretion in OVX mice was due to increased bone formation rate (as determined by bone histomorphometry) and increased serum procollagen peptide. In conclusion, contrary to the known estrogen effect as an initiator of GH/IGF surge and thereby pubertal growth spurt, our findings demonstrate that loss of estrogen and/or other hormones during the prepubertal growth period effect leads to an increase in IGF-I production and bone accretion in mice.

Indexed as

OvariectomyAdipose TissueAnimalsBody WeightBone and BonesBone DensityBone DevelopmentCollagen Type IEstrogensFemaleFemurGene ExpressionInsulin-Like Growth Factor Binding Protein 5Insulin-Like Growth Factor ILiverMiceCollagen Type Icollagen type I trimeric cross-linked peptideEstrogensInsulin-Like Growth Factor Binding Protein 5Insulin-Like Growth Factor IPeptide FragmentsPeptidesProcollagenprocollagen Type I N-terminal peptide

Identifiers

PMID18812464
PMCPMC2584807
OpenAlexW2127708258

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.